A purple and pink letter v on a white background.
July 28, 2021

Hair Restoration With ARTAS®: Nico’s Patient Journey

Hair transplantation is a  multi-billion dollar market with steady growth that shows no sign of slowing. Hair loss impacts over 50 million men worldwide and over two-thirds of men will experience some form of thinning or baldness before the age of 35. To meet the need of a growing number of men seeking hair restoration, technology has advanced by leaps and bounds to deliver pleasing, natural-looking results. ARTAS ® , a robotic hair transplant system enhanced with Artificial Intelligence, is Venus Concept’s state-of-the-art answer to hair restoration, gives clinicians the edge in providing an attractive hair loss solution to growing consumer demand. To highlight why ARTAS ® is the best option for clinics looking to tap into this lucrative market, we recently followed the patient journey of our contest winner Nico, who won the opportunity to have a hair restoration procedure performed by Dr. Gregory Turowski MD, Ph.D., FACS.

The ARTAS® Experience from Both Sides

Dr. Turowsky was impressed with the ARTAS ® hair transplantation technology from the beginning. An early adopter of the technology, his device quickly rose to the top of the charts, becoming fourth in the world for the number of procedures performed. He notes the precision, the repetitiveness, and the quality of the system, thanks to the Artificial Intelligence enhancing the equipment. The speed of the machine, he notes, is also something to take into consideration. On Nico, ARTAS ® was able to perform almost 2000 grafts per hour, meaning an entire procedure can be completed in a day, rather than over several days, maximizing the number of patients Dr. Turowsky’s clinic is able to treat. His patients, including Nico, appreciate that with ARTAS ® they have minimal pain, minimal scarring, and minimal downtime, with natural-looking results.

 

 

How ARTAS ® Differs from Other Devices

The ARTAS ® hair restoration device replaces the old method of manual Follicular Unit Extraction (FUE) with robotic FUE. Using advanced image-guided robotics, ARTAS ® precisely analyzes and dissects the best grafts from the patient’s donor area thousands of times per session, and then accurately identifies where they should be implanted to achieve a seamless,

natural-looking hairline that’s customized to each patient. Using an integrated Artificial Intelligence software, ARTAS ® enables accurate and efficient harvesting, recipient site-making, and implantation functionality in one device, using image-guided robotics for precise and repeatable follicular unit dissection.

Why ARTAS ® Is the Best Choice for Your Clinic

With ARTAS ® , you’re acquiring not only the cutting-edge hair restoration capabilities of the device—you’re also getting the benefit of Venus Concept’s robust support.

First and foremost, ARTAS ® was designed with patients in mind; however, the device is also optimized to make the transplantation process easier for providers. Robotic hair procedures are quicker, reducing the time and in-clinic costs associated with manual FUE hair restoration. In addition, ARTAS ® is equipped with a robotic arm that uses pneumatic pressure to extract and reinsert the follicles, eliminating what can be a physically strenuous session for practicians.

We’re also invested in building awareness and patient demand for the procedure. Because we’re continually positioning our devices as the best in the industry via our vast web presence, promotions, and social media, ARTAS ® comes with built-in brand recognition. Your clinic can leverage that recognition to its own benefit by offering clients technology that they already know, respect, and trust.

In particular, we focus special attention on educating and informing people who may feel reluctant to take the major step of getting surgery for their hair loss. To this day, many clients are still concerned about the stigma of baldness and undergoing hair restoration treatments. By augmenting the experience with robotics and a futuristic AI program, and through initiatives like our patient contest, we’re transforming the public image of hair restoration to one that’s positive and exciting.

All of our cutting-edge medical aesthetic devices are backed by Venus Concept’s scientific research and thorough clinical trials. We stand by them, and we want your clinic to succeed as much as you do. We’re here to support your practice through our practice enhancement program , our easy-entry subscription plans , and a wealth of expertise in marketing and growing aesthetic businesses. First and foremost, our competitive pricing model excludes hidden fees or pay-per-use gimmicks, allowing you to get the best return on your investment—and to pass those savings onto your clients.

Last year, a record-breaking number of ARTAS ® hair restoration procedures were performed, proving that there’s never been a better time to offer hair restoration at your clinic .

To speak to an expert today about the future of hair restoration and what ARTAS ® can do for your clinic, contact us using the button below.

September 9, 2026
TORONTO, September 9 th , 2026 (GLOBE NEWSWIRE) – Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced the appointment of Brad Oliver as Chief Executive Officer, effective as of September 7, 2026. He succeeds Rajiv De Silva, who will assume the role of Special Advisor to support a seamless leadership transition. The Board believes that Brad’s commercial leadership experience, strategic vision, and industry expertise position the Company well for its next phase of growth and value creation. Brad brings more than 20 years of leadership experience in the aesthetic industry, most recently as President & General Manager – Americas at Lumenis, and has a proven track record of driving growth globally, operational excellence, and innovation. "I am honored to be appointed Chief Executive Officer of Venus Concept and grateful for the confidence the Board has placed in me,” said Mr. Oliver. “The Company has established a strong foundation under Rajiv's leadership, and I look forward to working closely with him during the transition. Together with our employees, customers, and partners, we will remain focused on disciplined commercial execution, product innovation, profitable growth, and creating long-term value for our customers, employees, and shareholders.” “It has been a pleasure to lead Venus through a transformational time in the organization’s journey,” said Mr. De Silva. “I am grateful for the opportunity to work together with the leadership team, the Board and our partners to grow the business. We have transformed the commercial, operational and financial capabilities of the organization and built a strong foundation for the future. I remain highly confident in the Company’s strategy, pipeline and long-term growth opportunities. I look forward to supporting a smooth transition and watching Venus continue its transformation under Brad’s new leadership.” The Board expresses its gratitude to Rajiv for his leadership and ongoing commitment to the Company. As Special Advisor, Rajiv will work closely with Brad during the transition period to ensure continuity across strategic, operational, and customer-facing initiatives. “On behalf of the Board, I would like to thank Rajiv for his leadership and contributions to the Company and for his support during this transition to ensure a seamless handoff of leadership responsibilities,” said Avinash Amin, M.D., Managing Partner of Madryn Asset Management and Chairman of the Board. “The Board looks forward to Brad’s new leadership of the organization and is confident that his expertise will accelerate commercial efforts globally and the execution of its strategic priorities as the company progresses towards continuing to establish a leadership position in the Medical Device Aesthetics industry.” The leadership transition is not expected to impact the Company’s strategic priorities, customer relationships, employee commitments, or ongoing business operations. Venus Concept remains focused on delivering innovative solutions to its customers, expanding market opportunities, and driving sustainable long-term growth. About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft ® and the ARTAS iX ® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. View Full Article Investor Relations Contact : Damian Yeung, CPA investorrelations@venus.ai
Purple gradient branding graphic for Doublo × Venus Signature Edition
July 28, 2026
TORONTO, July 28, 2026 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”), a global medical aesthetic technology leader, today announced it has entered into an exclusive distribution agreement with HIRONIC Co. Ltd. (“HIRONIC”), a KOSDAQ listed South Korean company specializing in medical aesthetic devices, pursuant to which the Company acquires the exclusive right to distribute HIRONIC’s Doublo 2.0 device in the United States and Canada. The “New Doublo 2.0” is a synergistic, multi-energy-based medical device platform for the face and body, equipped with two separate handpieces that enables clinics to offer customer Cold Plasma and RF microneedling treatments. The device has received 510(k) certification from the U.S. Food and Drug Administration, and the Company intends to make it available to customers in the United States during 2H 2026. Venus Concept will support future regulatory approval efforts in Canada for the device and any additional handpiece technologies for both regions. “HIRONIC is a global leader in developing innovative medical aesthetic technologies and we are excited for the new partnership, starting with the Doublo x Venus Signature Edition,” said Rajiv De Silva, Chief Executive Officer of Venus Concept. “With this device, we look forward to offering our customers an innovative, exclusive Cold Plasma and RF Microneedling platform. By combining these complementary technologies, the platform delivers synergistic effects from the epidermis to the dermis, enabling comprehensive skin rejuvenation by addressing multiple skin concerns and enhancing overall skin revitalization. The Doublo also complements our existing portfolio by enhancing the range of treatment modalities for a customizable treatment plan to address each patient’s skin needs. We aim to expand our partnership in the future to bring to our customers additional new and novel technologies from HIRONIC, once regulatory approvals have been obtained.” About Venus Concept Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept is backed by Madryn Asset Management, a leading healthcare investment firm that provides capital to innovative growth-stage healthcare companies offering unique and transformative products and technologies. Investor Relations Contact: Damian Yeung, CPA investorrelations@venus.ai View Full Article
May 22, 2026
Skin Cancer Awareness Month highlights prevention and early detection. Learn how dermatologists support care with advanced tools and treatments.